Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Rosuvastatin/Ezetimibe vs Rosuvastatin in ASCVD Patients with Type 2 Diabetes
NCT03597412Phase 4Completed
- Sponsor
- Yuhan
- Start
- Oct 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe + rosuvastatin in atherosclerotic cardiovascular disease (ASCVD), hypercholesterolemia, sponsored by Yuhan. Started Oct 2018; status: completed.
02
Drugs
ezetimibe + rosuvastatin
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)hypercholesterolemia
Beyond the preview
Go deeper on NCT03597412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03597412.